• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Brazilian National System for the Monitoring and Improvement of Compounding Practices: program outcomes.

作者信息

de Souza Hugo Guedes, Favaro Alvaro, Andrade Alba Lívia, Gomes Lenir Yago, Garcez Maria do Carmo

机构信息

Brazilian National Association of Compounding Pharmacies (ANFARMAG), São Paulo, SP, Brazil.

出版信息

Int J Pharm Compd. 2012 Mar-Apr;16(2):98-102.

PMID:23050320
Abstract

Compounding pharmacies in Brazil have to comply with a complex and strict set of drug manufacturing regulations. The authors reported in the International Journal of Pharmaceutical Compounding (November/December 2009, Volume 13, Issue 6) on the development and implementation of a National System for the Monitoring and Improvement of Compounding Practices in Brazil, a process-focused program aiming to help compounding pharmacies improve drug manufacturing processes and meet the standards set forth by the applicable legislation This article reports the results obtained in the first three editions of the National System for the Monitoring and Improvement of Compounding Practices in Brazil (2006-2010) and presents new foci explored in the 2011 cycle. The results obtained over the years demonstrate that participating in the National System for the Monitoring and Improvement of Compounding Practices in Brazil has helped pharmacies achieve legal compliance and improve the quality of their preparations, which has contributed substantially to meeting quality standards never before achieved in the compounding sector in Brazil.

摘要

相似文献

1
Brazilian National System for the Monitoring and Improvement of Compounding Practices: program outcomes.
Int J Pharm Compd. 2012 Mar-Apr;16(2):98-102.
2
WHO Expert Committee on Specifications for Pharmaceutical Preparations.世界卫生组织药物制剂规范专家委员会
World Health Organ Tech Rep Ser. 1999;885:i-vi, 1-156.
3
Performance Improvement in 503A Compounding Pharmacies: A PLAN FOR ASSESSMENT, IMPLEMENTATION, AND SUSTAINED SUCCESS.503A 配制药房的绩效改进:评估、实施及持续成功计划
Int J Pharm Compd. 2016 Jan-Feb;20(1):29-36.
4
Pharmaceutical compounding or pharmaceutical manufacturing? A regulatory perspective.药物配制还是药物生产?监管视角。
Int J Pharm Compd. 2014 Mar-Apr;18(2):101-11.
5
Survey of sterile product compounding practices in Canadian hospital pharmacies.加拿大医院药房无菌产品配制实践调查。
Can J Hosp Pharm. 1993 Dec;46(6):249-60.
6
[An analysis of the pharmaceuticals market in Vietnam].[越南药品市场分析]
Sante. 2001 Jul-Sep;11(3):155-60.
7
Compounding practices in Iran.伊朗的配药实践。
Int J Pharm Compd. 2014 Mar-Apr;18(2):112-6.
8
Setting up a national system of compounding pharmacies: preventing error, assuring quality, building trust.建立全国性的复方药房体系:预防差错、确保质量、建立信任。
Int J Pharm Compd. 2009 Nov-Dec;13(6):532-6.
9
2013 State Compounding Legislation Tracker.
Int J Pharm Compd. 2013 Sep-Oct;17(5):375-8.
10
Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.欧洲药品配制的监管框架及立法的实际发展情况。
Health Policy. 2014 Sep;117(3):328-33. doi: 10.1016/j.healthpol.2014.07.010. Epub 2014 Jul 18.